Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Manon G. van der Meer"'
Autor:
Anouk Achten, Steven A. Muller, Sandra Sanders-van Wijk, Manon G. van der Meer, Pim van der Harst, Peter van Tintelen, Anneline SJM te Riele, Vanessa van Empel, Marish IFJ Oerlemans, Christian Knackstedt
Publikováno v:
Annals of Medicine, Vol 56, Iss 1 (2024)
Introduction Current guidelines recommend suspecting transthyretin amyloid cardiomyopathy (ATTR-CM) in patients over 65 years of age with unexplained left ventricular (LV) hypertrophy in a non-dilated LV, heart failure (HF) and preserved ejection fra
Externí odkaz:
https://doaj.org/article/8b472de1026247aaa03ccd9ce0f3f4bb
Autor:
Lieke Numan, Emmeke Aarts, Faiz Ramjankhan, Marish I. F. Oerlemans, Manon G. van der Meer, Nicolaas de Jonge, Anne‐Marie Oppelaar, Hans Kemperman, Folkert W. Asselbergs, Linda W. Van Laake
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 2 (2024)
Background Soluble suppression of tumorigenicity‐2 (sST2) predicts mortality in patients with heart failure. The predictive value of sST2 in patients with a left ventricular assist device remains unknown. Therefore, we studied the relationship betw
Externí odkaz:
https://doaj.org/article/42b2e3fe935f4a04850feeaa419fd5a9
Autor:
Lauren Dautzenberg, Lieke Numan, Wilma Knol, Monica Gianoli, Manon G. van der Meer, Anne-Marie Troost-Oppelaar, Aline F. Westendorp, Marielle H. Emmelot-Vonk, Linda W. van Laake, Huiberdina L. Koek
Publikováno v:
American Heart Journal Plus, Vol 24, Iss , Pp 100233- (2022)
Background: The prevalence of (hyper)polypharmacy in patients on left ventricular assist device (LVAD) support and its effect on clinical outcomeis unknown. Therefore, we aimed to determine the prevalence of (hyper)polypharmacy in LVAD patients and e
Externí odkaz:
https://doaj.org/article/630e8a9ebd7b4b5f87003ac2c53f7cd4
Autor:
Peter-Paul Zwetsloot, Wouter L. Smit, Niels P. Van der Kaaij, Mariusz K. Szymanski, Manon G. Van der Meer, Linda W. Van Laake, Annet Troelstra, Marjolijn C. A. Wegdam-Blans, Marish I. F. J. Oerlemans
Publikováno v:
Biomedicines, Vol 11, Iss 8, p 2103 (2023)
Introduction: From the start of the coronavirus disease 2019 (COVID-19) pandemic, international guidelines have recommended pre-operative screening for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) before heart transplantation (HTx). D
Externí odkaz:
https://doaj.org/article/fdfa56b4a81d4040bb129747742f09f4
Autor:
Pascal M. Burger, Aruna D. Pradhan, Jannick A.N. Dorresteijn, Stefan Koudstaal, Martin Teraa, Gert J. de Borst, Manon G. van der Meer, Arend Mosterd, Paul M. Ridker, Frank L.J. Visseren
Publikováno v:
The American Journal of Cardiology. 197:13-23
Autor:
Pascal M. Burger, Stefan Koudstaal, Jannick A.N. Dorresteijn, Gianluigi Savarese, Manon G. van der Meer, Gert J. de Borst, Arend Mosterd, Frank L.J. Visseren
Publikováno v:
International Journal of Cardiology. 379:66-75
Autor:
Maria C, Castelijns, Steven H J, Hageman, Ynte M, Ruigrok, Manon G, van der Meer, Martin, Teraa, Jan, Westerink, Frank L J, Visseren
Publikováno v:
Obesity Research & Clinical Practice. 17:40-46
To determine the association between both visceral fat quantity and adipose tissue dysfunction, and major bleeding in patients with established cardiovascular disease.Patients from the Second Manifestations of ARTerial disease study with established
Autor:
Maria C. Castelijns, Steven H.J. Hageman, Martin Teraa, Manon G. van der Meer, Jan Westerink, Francesco Costa, Jurriën M. ten Berg, Frank L.J. Visseren
Publikováno v:
American Heart Journal, 260, 72-81. MOSBY-ELSEVIER
Objective The long-term predictive performance of existing bleeding risk models in patients with various manifestations of cardiovascular disease (CVD) is not well known. This study aims to assess and compare the performance of relevant existing blee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d42c589e0395728df72e99275ee8a551
https://cris.maastrichtuniversity.nl/en/publications/21bd10c1-c283-4e56-8a40-b9666ddb30c9
https://cris.maastrichtuniversity.nl/en/publications/21bd10c1-c283-4e56-8a40-b9666ddb30c9
Autor:
Lieke Numan, Emmeke Aarts, Faiz Ramjankhan, Marish I.F. Oerlemans, Manon G. van der Meer, Nicolaas de Jonge, Anne-Marie Oppelaar, Hans Kemperman, Folkert W. Asselbergs, Linda W. Van Laake
BackgroundSoluble suppression of tumorigenicity-2 (sST2) predicts mortality in heart failure patients. The predictive value of sST2 in left ventricular assist device (LVAD) patients remains unknown. Therefore, we studied the relationship between sST2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee6ac963e040cd197c2c74894f1a4237
https://doi.org/10.1101/2023.02.06.23285564
https://doi.org/10.1101/2023.02.06.23285564
Publikováno v:
JACC. Heart failure. 11(1)